¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦ 1Â÷ ´ëÇÑ¿©µå¸§ÁÖ»çÇÐȸ ±³À° ½ÉÆ÷Áö¿ò (1st annual Korean Acne and Rosacea Scientific Insight Symposium) : 2023-03-11

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦ 1Â÷ ´ëÇÑ¿©µå¸§ÁÖ»çÇÐȸ ±³À° ½ÉÆ÷Áö¿ò (1st annual Korean Acne and Rosacea Scientific Insight Symposium) : 2023-03-11
±³À°ÀÏÀÚ : 2023-03-11
±³À°Àå¼Ò : ¼­¿ï¼º¸ðº´¿ø ÁöÇÏ 1Ãþ ´ë°­´ç  
±³À°ÁÖÁ¦ : Á¦ 1Â÷ ´ëÇÑ¿©µå¸§ÁÖ»çÇÐȸ ±³À° ½ÉÆ÷Áö¿ò (1st annual Korean Acne and Rosacea Scientific Insight Symposium)
ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ¿©µå¸§ÁÖ»çÇÐȸ  
´ã´çÀÚ : °íÁÖ¿¬ ±³¼ö
¿¬¶ôó : 02-2290-8441  
À̸ÞÀÏ : drko0303@hanyang.ac.kr      
±³À°Á¾·ù : ÇǺΰú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 500,000¿ø      
ºñ°í ´ëÇÑÇǺΰúÇÐȸ ȸ¿ø(ÇǺΰú Àü°øÀÇ Æ÷ÇÔ): ¹«·á /ºñȸ¿ø: 50¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-11 ÁöÇÏ 1Ãþ ´ë°­´ç 13:00~13:30 Looking through acne comorbidities  ½Å¹Î°æ(°æÈñÀÇ´ë) 
±³À°½Ã°£ 03-11 ÁöÇÏ 1Ãþ ´ë°­´ç 13:30~14:00 Prevalence and management of acne in atopic dermatitis patients  ±èÇý¼º(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 03-11 ÁöÇÏ 1Ãþ ´ë°­´ç 14:00~14:30 Prevalence and management of acne and rosacea in psoriasis patients  ±èÁ¤Àº(¼øõÇâÀÇ´ë) 
È޽Ġ03-11 ÁöÇÏ 1Ãþ ´ë°­´ç 14:30~14:50   () 
±³À°½Ã°£ 03-11 ÁöÇÏ 1Ãþ ´ë°­´ç 14:50~15:20 Recent advances in understanding of rosacea  ÃÖÈÆ(Á¶¼±ÀÇ´ë) 
±³À°½Ã°£ 03-11 ÁöÇÏ 1Ãþ ´ë°­´ç 15:20~15:50 Advances in the treatment of rosacea  ÃÖÀ¯¼º(¼øõÇâÀÇ´ë) 
È޽Ġ03-11 ÁöÇÏ 1Ãþ ´ë°­´ç 15:50~16:10   () 
±³À°½Ã°£ 03-11 ÁöÇÏ 1Ãþ ´ë°­´ç 16:10~16:40 Recent advances in understanding of hidradenitis suppurativa (HS)  ÀÌ¿µº¹(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 03-11 ÁöÇÏ 1Ãþ ´ë°­´ç 16:40~17:10 HS: Adalimumab clinical study data and post marketing surveillance  ÀÌÈñÁ¤(Â÷ÀÇ´ë) 
±³À°½Ã°£ 03-11 ÁöÇÏ 1Ãþ ´ë°­´ç 17:10~17:40 HS: Secukinumab clinical study data and potential new drugs  ¹Ú±Í¿µ(Áß¾ÓÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦ 1Â÷ ´ëÇÑ¿©µå¸§ÁÖ»çÇÐȸ ±³À° ½ÉÆ÷Áö¿ò (1st annual Korean Acne and Rosacea Scientific Insight Symposium) : 2023-03-11""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023 ÀüºÏ³»°úÀÇ»çȸ Çмú´ëȸ : 2023-03-11
´ÙÀ½±Û ÀÎÁ¦´ëÇб³ ÇØ¿î´ë¹éº´¿ø 2023 8th Busan Shoulder and Elbow Symposium (Inje University Haeundae Paik Hospital) : 2023-03-11
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20775 ¼­¿ï 2024³â °áÇÙ°ü¸®±³À° 1±â(1ÀÏÂ÷) : 2024-06-13 0 0 2024-05-27
20774 ºÎ»ê (¿Â¶óÀÎ) ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ ºÎ»ê¡¤¿ï»ê¡¤°æ³² ÁöºÎȸ 2024³â 06¿ù Çмú´ëȸ : 2024-06-13 0 0 2024-05-27
20773 ´ëÀü 2024 Á¦40ȸ ´ëÇѼҾƿܰúÇÐȸ Ãá°èÇмú´ëȸ ¹× 40Áֳ⠱â³äÇà»ç(1ÀÏÂ÷) : 2024-06-13 0 1 2024-05-27
20772 ´ë±¸ 2024 Á¦2Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ ´ë±¸°æºÏÁöºÎÇÐȸ : 2024-06-13 0 3 2024-05-27
20771 ¼­¿ï ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2024³â Á¦19Â÷ Çмú´ëȸ (1ÀÏÂ÷) : 2024-06-13 0 4 2024-05-27
20770 ¼­¿ï 2024 ´ëÇÑÈ­»óÇÐȸ Çмú´ëȸ(1ÀÏÂ÷) : 2024-06-13 0 2 2024-05-27
20769 ¼­¿ï 2024³â ±Ýõ±¸ÀÇ»çȸ 1Â÷ ¿¬¼ö±³À°(¿ì¿ïÁõ ¾àÁ¦, ÇǺÎÁúȯ, CBC¿Í LFT, À§¿°) : 2024-06-12 0 0 2024-05-27
20768 ¼­¿ï 2024 Á¦3ȸ ÀÌ°ÇÈñ ¼Ò¾Æ¾Ï¡¤Èñ±ÍÁúȯ ±Øº¹»ç¾÷ ¿¬±¸ÀÚ SKILL-UP Workshop : 2024-06-12 0 0 2024-05-27
20767 °æ±â ´ëÇÑÇǺΰúÇÐȸ Á¦78Â÷ °æ±âÁöºÎȸ ÇмúÁý´ãȸ : 2024-06-11 0 0 2024-05-27
20766 ±¤ÁÖ Á¦180Â÷ ´ëÇѼҾÆû¼Ò³â°úÇÐȸ ±¤ÁÖ¡¤Àü³²Áöȸ ÇмúÁý´ãȸ : 2024-06-11 0 2 2024-05-27
20765 ºÎ»ê ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ºÎ»ê,¿ï»ê,°æ³²Áöȸ - Á¦362Â÷ ¿ù·ÊÇмúȸ : 2024-06-11 0 10 2024-05-27
20764 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ±âº»±³À° : 2024-06-11 0 5 2024-05-27
20763 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ(ÀÇ»ç) ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ½ÉÈ­±³À° : 2024-06-11 0 5 2024-05-27
20762 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾÆÀÀ±ÞÀÇÇÐȸ Á¦ 32ȸ Á¤±â Áý´ãȸ : 2024-06-10 0 5 2024-05-27
20761 ¼­¿ï °í·Á´ëÇб³±¸·Îº´¿ø Á¦16ȸ KOALA Symposium 2024 : 2024-06-09 0 1 2024-05-27
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷